United Kingdom · Question · Written question
UIN 53391
Ritlecitinib: Alopecia
Introduced
19 May 2025
Last action
23 May 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 May 2025
Summary
To ask the Secretary of State for Health and Social Care, whether he plans to update guidance on the use of Ritlecitinib to treat alopecia.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 May 2025
Written question
To ask the Secretary of State for Health and Social Care, whether he plans to update guidance on the use of Ritlecitinib to treat alopecia.
Source: Commons
23 May 2025
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-05-19/53391
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1804128
- uk · wq-1804128 · source updated 23 May 2025